<?xml version="1.0" encoding="UTF-8"?>
<p>To date, all four drugs are being independently tested in randomised controlled trials, mostly national, to investigate their efficacy and safety in the management of SARS‐CoV‐2 disease. Several European countries have also set up, as a result of joint efforts since mid‐March, a randomised, multicentre, open‐label phase 3 trial to evaluate and compare the efficacy and toxicity of the first three treatments mentioned above.
 <xref rid="bjo16270-bib-0026" ref-type="ref">
  <sup>26</sup>
 </xref>
</p>
